Top Suppliers:I want be here
Related CAS#:
141196-85-2 145918-75-8
141196-84-1 1158522-08-7
940364-43-2 2701285-45-0
134104-43-1 131615-57-1
6906-52-1 2248402-59-5
930439-75-1 1018584-77-4
1375289-11-4

145918-75-8

145918-75-8 structure
145918-75-8 structure
  • Name: Troxacitabine
  • Chemical Name: 4-amino-1-[(2S,4S)-2-(hydroxymethyl)-1,3-dioxolan-4-yl]pyrimidin-2-one
  • CAS Number: 145918-75-8
  • Molecular Formula: C8H11N3O4
  • Molecular Weight: 213.19100
  • Catalog: Research Areas Cancer
  • Create Date: 2018-06-17 12:43:42
  • Modify Date: 2024-01-22 10:50:56
  • Troxacitabine is nucleoside analog with potent anticancer activity.
Name 4-amino-1-[(2S,4S)-2-(hydroxymethyl)-1,3-dioxolan-4-yl]pyrimidin-2-one
Synonyms S1535_Selleck
Bch-4556
cis-Dioxolane-C
Troxacitabine
Description Troxacitabine is nucleoside analog with potent anticancer activity.
Related Catalog
In Vitro Troxacitabine has shown cutotoxicity in cancer cell lines of hepatocellular (HepG2), prostate (PC3, DUI45), non-small cell lung (NCI-H460, NCr-322M) colon (HT29), renal (CAK-l, A498, RXF-393, SNI2-C) and pancreatic origin (Pnac-Ol, MiaPa Ca) with IC50s range from 15-35 μM[1][2].
In Vivo Troxacitabine is highly active against the Panc-01 model, with TGI levels of 88.5% and 84.3% at the 10 and 25 mg/kg doses, respectively. The mean final tumor weights for animals given troxacitabine are also significantly smaller compared with vehicle controls. Troxacitabine has less activity against the MiaPaCa model[3]. Troxacitabine is very effective in human RCC tumor xenograft models, including CAM-i, A498, RXF-393, and SN12C carcinomas. Very good responses are ob served in animals bearing CAM-i, A498, and RXF-393 RCC tumors given i.p. doses of 10, 25, and 50 mg/kg twice a day for 5 days[2].
Animal Admin Mice[3] Troxacitabine is administered i.v. to the animals at doses of 10 and 25 mg/kg on a daily 3 5 regimen. Gemcitabine is used as a positive control. The end points for the study included tumor growth inhibition (TGI), final weight, and the number of partial and complete tumor responses in the animals[3].
References

[1]. Gourdeau H, et al. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts. Cancer Chemother Pharmacol. 2002 Dec;50(6):490-6.

[2]. Kadhim SA, et al. Potent antitumor activity of a novel nucleoside analogue, BCH-4556 (beta-L-dioxolane-cytidine), in human renal cell carcinoma xenograft tumor models. Cancer Res. 1997 Nov 1;57(21):4803-10.

[3]. Weitman S, et al. The new dioxolane, (-)-2'-deoxy-3'-oxacytidine (BCH-4556, troxacitabine), has activity againstpancreatic human tumor xenografts. Clin Cancer Res. 2000 Apr;6(4):1574-8.
Density 1.71g/cm3
Boiling Point 422.5ºC at 760mmHg
Molecular Formula C8H11N3O4
Molecular Weight 213.19100
Flash Point 209.3ºC
Exact Mass 213.07500
PSA 99.60000
Vapour Pressure 6.59E-09mmHg at 25°C
Index of Refraction 1.694
HS Code 2933599090
HS Code 2933599090
Summary 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Chemsrc provides CAS#:145918-75-8 MSDS, density, melting point, boiling point, structure, formula, molecular weight, synthetic route, etc.
title: CAS No. 145918-75-8 | Chemsrc address: https://m.chemsrc.com/en/baike/672635.html

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved